An anti-CRISPR protein disables type V Cas12a by acetylation.
Dong, L., Guan, X., Li, N., Zhang, F., Zhu, Y., Ren, K., Yu, L., Zhou, F., Han, Z., Gao, N., Huang, Z.(2019) Nat Struct Mol Biol 26: 308-314
- PubMed: 30936526 
- DOI: 10.1038/s41594-019-0206-1
- Primary Citation of Related Structures:  
6IV6, 6IUF - PubMed Abstract: 
Phages use anti-CRISPR proteins to deactivate the CRISPR-Cas system. The mechanisms for the inhibition of type I and type II systems by anti-CRISPRs have been elucidated. However, it has remained unknown how the type V CRISPR-Cas12a (Cpf1) system is inhi ...